Combined Thrombophilic Mutations in Women with Unexplained Recurrent Miscarriage
暂无分享,去创建一个
G. Vartholomatos | A. Sotiriadis | S. Kalantaridou | E. Paraskevaidis | T. Stefos | N. Kolaitis | M. Pavlou | Leucothea Dova
[1] P. Langhorne,et al. Thrombophilia in pregnancy: a systematic review , 2006, British journal of haematology.
[2] C. Coulam,et al. Multiple thrombophilic gene mutations rather than specific gene mutations are risk factors for recurrent miscarriage. , 2004, American journal of reproductive immunology.
[3] F. Sánchez-Jiménez,et al. An in vitro evaluation of the effects of homocysteine thiolactone on key steps of angiogenesis and tumor invasion. , 2003, Biochemical and biophysical research communications.
[4] C. Oberkanins,et al. Plasminogen activator inhibitor 1 4G/5G polymorphism and coagulation factor XIII Val34Leu polymorphism: impaired fibrinolysis and early pregnancy loss. , 2003, Clinical chemistry.
[5] G. Heinze,et al. Combined thrombophilic polymorphisms in women with idiopathic recurrent miscarriage. , 2003, Fertility and sterility.
[6] S. Kahn,et al. Thrombophilic disorders and fetal loss: a meta-analysis , 2003, The Lancet.
[7] G. Vartholomatos,et al. Prevalence of the G20210A prothrombin gene mutation in Northwestern Greece and association with venous thromboembolism. , 2003, International angiology : a journal of the International Union of Angiology.
[8] S. Schellong,et al. Coagulation factor V G allele and HR2 haplotype: factor V activity, activated protein C resistance and risk of venous thrombosis , 2003, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[9] G. Vartholomatos,et al. Lack of association between the C677T mutation in the 5,10-methylenetetrahydrofolate reductase gene and venous thromboembolism in Northwestern Greece. , 2002, International angiology : a journal of the International Union of Angiology.
[10] F. Sánchez-Jiménez,et al. Anti-angiogenic effects of homocysteine on cultured endothelial cells. , 2002, Biochemical and biophysical research communications.
[11] N. Sebire,et al. Defective endovascular trophoblast invasion in primary antiphospholipid antibody syndrome-associated early pregnancy failure. , 2002, Human reproduction.
[12] K. Blennow,et al. Increased frequency of combined methylenetetrahydrofolate reductase C677T and A1298C mutated alleles in spontaneously aborted embryos , 2002, European Journal of Human Genetics.
[13] W. Hooper,et al. Factor V Leiden and Factor V R2 Allele: High-throughput Analysis and Association with Venous Thromboembolism , 2001, Thrombosis and Haemostasis.
[14] T. Kohlmann,et al. Selection pressure for the factor-V-Leiden mutation and embryo implantation , 2001, The Lancet.
[15] C. P. Morris,et al. The factor V HR2 haplotype: prevalence and association of the A4070G and A6755G polymorphisms , 2001, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[16] G. Vartholomatos,et al. The prevalence of factor V Leiden as a risk factor for venous thromboembolism in the population of North-Western Greece. , 2000, International angiology : a journal of the International Union of Angiology.
[17] F. Rosendaal,et al. The HR2 Haplotype of Factor V Is not Associated with the Risk of Myocardial Infarction , 2000, Thrombosis and Haemostasis.
[18] E. Yilmaz,et al. Factor V (His 1299 Arg) in Young Turkish Patients with Cerebral Infarct , 2000, Pathophysiology of Haemostasis and Thrombosis.
[19] T. Agorastos,et al. Factor V leiden and prothrombin G20210A mutations, but not methylenetetrahydrofolate reductase C677T, are associated with recurrent miscarriages. , 2000, Human reproduction.
[20] E. Gabazza,et al. The zymogen prothrombin stimulates cell locomotion and calcium influx in murine osteosarcoma cells by different mechanism from thrombin. , 1999, International journal of oncology.
[21] C. Conlon,et al. A longitudinal study of pregnancy outcome following idiopathic recurrent miscarriage. , 1999, Human reproduction.
[22] R. Matalon,et al. Methylenetetrahydrofolate reductase (MTHFR): the incidence of mutations C677T and A1298C in the Ashkenazi Jewish population. , 1999, American journal of medical genetics.
[23] Y. Friedlander,et al. A common mutation A1298C in human methylenetetrahydrofolate reductase gene: association with plasma total homocysteine and folate concentrations. , 1999, The Journal of nutrition.
[24] E. Oger,et al. Hormone Replacement Therapy and Circulating ICAM-1 in Postmenopausal Women , 1999, Thrombosis and Haemostasis.
[25] V. Nicaud,et al. The Factor V Gene A4070G Mutation and the Risk of Venous Thrombosis , 1999, Thrombosis and Haemostasis.
[26] B. Pentecost,et al. Role of thrombin receptor in breast cancer invasiveness , 1999, British Journal of Cancer.
[27] R. Rozen,et al. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. , 1998, Molecular genetics and metabolism.
[28] P. Reitsma,et al. A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. , 1996, Blood.
[29] F. Rosendaal,et al. Increased fetal loss in women with heritable thrombophilia , 1996, The Lancet.
[30] B. Dahlbäck,et al. Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C. , 1994, The Journal of clinical investigation.
[31] G. Hardy. MENDELIAN PROPORTIONS IN A MIXED POPULATION. , 1908 .
[32] E. Jauniaux,et al. Trophoblastic oxidative stress in relation to temporal and regional differences in maternal placental blood flow in normal and abnormal early pregnancies. , 2003, The American journal of pathology.
[33] C. Oberkanins,et al. Plasminogen Activator Inhibitor 1 4 G / 5 G Polymorphism and Coagulation Factor XIII Val 34 Leu Polymorphism : Impaired Fibrinolysis and Early Pregnancy Loss , 2003 .
[34] D. Girelli,et al. Functional Properties of Factor V and Factor Va Encoded by the R2-gene , 2001, Thrombosis and Haemostasis.
[35] R. Matthews,et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase , 1995, Nature Genetics.